Current studies have shown that in HCC patient tissues, overexpression of ANXA5 is associated in a positive way with the up-regulation of CRKI/II and RAC1, thus promoting the clinical progression and lymphatic metastasis of HCC (26, 27). Here, ANXA5 is linked to hepatocellular carcinoma.